MediciNova Announces Results From a Phase II/III Interstitial Cystitis
Phramalive.com - on 500 mg of MN-001 administered twice a day compared to placebo (25% compared to 12%, p=0.04) after 4 weeks of treatment including asthma, multiple sclerosis, status asthmaticus, interstitial cystitis, cancer, Generalized Anxiety Disorder, insomnia
Source: www.pharmalive.com
Click here for more information about separation anxiety suggestions
<< Home